There was a paper from one of the Fed branch offices about this. It turns out that the US has two independent mechanisms to help pharma companies make money: patents and FDA-granted exclusivity. It's unclear that patents are needed.
I admit I don't know much about the latter, but what about international markets?
There was a paper from one of the Fed branch offices about this. It turns out that the US has two independent mechanisms to help pharma companies make money: patents and FDA-granted exclusivity. It's unclear that patents are needed.